Released on: March 25, 2008, 12:20 am

Press Release Author: Shlomit Weisblum

Industry: Biotech

Press Release Summary: Top Italian medical device distributor NGC Medical signed the
contract even before products were awarded CE Mark to ensure exclusivity
Four new products will be exhibited at the EAU 2008 Conference in Milan

Press Release Body:
Caesarea, Israel - March 25, 2008 - Allium Medical Group, developer and manufacturer
of anatomically and functionally compatible, dynamic, large-caliber, removable,
non-vascular stents, announced today that it has signed an exclusive distribution
deal with Italian medical device distributor NGC Medical S.p.A., for both its
ureteral and biliary stents. The value of the deal was not disclosed.

Allium Medical will be exhibiting four new products based on its revolutionary
stenting platform at the EAU European Association of Urology World Congress in
Milan, Italy, March 26-28, 2008, Booth #A14.

Founded in 2001, Allium develops site-specific stents for various uses with
applications in the urinary and gastro-intestinal tract. Allium completed CE Marking
for its biliary and ureteral stents, and commenced distribution of its biliary
stents as of June 2007 in Italy, Sweden, Germany and Austria. Follow-on orders have
been received and delivered.

Based in the Milan area, NGC Medical is a leading distributor of medical devices
with a particular focus on innovative products. Allium's biliary stent was first
used for transhepatic treatment by radiologists, followed by successful insertions
of Allium's endoscopic biliary stent by gastroenterologists at Santo Spirito
Hospital, Casale Monferrato, under Dr. Carlo Poletti; Ospedale San Giovanni Battista
(Molinette), Torino, under Dr. Aldo Garbarini; and at Ospedale di Circolo e
Fondazione Macchi, Varese under Prof. Giampaolo Carrafiello. Ureteral stent
insertions are scheduled for mid-2008.

Dr. Paolo Cremascoli, President and CEO of NGC Medical S.p.A, said, "NGC was the
exclusive distributor in Italy of InStent Inc. which produced the UroCoil,
ProstaCoil, EndoCoil, EsophaCoil, etc., a highly successful stent family also
developed by Prof. Daniel Yachia. We are very happy to renew our relationship in
launching the new Allium Stents: the first easily removable, self-expandable, large
caliber, fully covered stent family especially designed for use in the urinary and
biliary tracts. Our initial sales were for first insertions at medical centers in
northern Italy. Based on successful results, we are now submitting bids to make the
Allium Stent widely available throughout Italy." Cremascoli added that NGC had
signed contracts with Allium in 2006, even before the products had been awarded CE
Mark, so as to ensure it had exclusive distribution rights.

Prof. (Em.) Daniel Yachia, M.D., President, CSO and Senior Consultant (Urology) for
the Allium Group, said, "NGC's support of this new product is testament to their
commitment to innovations such as Allium's technological platform, which can be
adapted to suit almost any stent-treatable site. Now, every organ can have a stent
of its own."

The four new products presented in Milan this week are the Allium ureteral stent;
the Allium prostatic stent; the Allium bulbar urethral stent and the Allium
bladder-neck stent.

About Allium Medical
Allium Medical, Inc., is a medical device company offering next-generation stents
based on a revolutionary technological platform that enables physicians to offer
more effective stent solutions for enhancing patients\' quality of life. Allium
Medical has developed site-specific, anatomically compatible stents with
applications in the urinary and gastro-intestinal tract. Founded in 2001, Allium
Medical is a privately owned company led by Professor Daniel Yachia M.D., an
urologist and acknowledged international authority on urinary system stenting.
Allium was awarded two CE marks for its biliary and ureteral stents, commenced sales
in Europe in June 2007 and received follow- on orders from its distributors.
Allium's headquarters, manufacturing and R&D facilities are located in Caesarea,
Israel. For more information: www.allium-medical.com

About NGC Medical
Founded by Dr. Eugenio Cremascoli, the main business focuses of NGC Medical S.p.A.
are: Project planning, manufacturing and marketing of medical and surgical devices;
Import and distribution in national territory of medical devices, medical data
management systems, medical communications database for remote access and medical
equipment;
Design and turnkey implementation of Surgery Units, Intensive Care, Hemodynamics,
Electrophysiology and Intervention Radiology Laboratories; In-service management of
Surgical Suites, Intensive Care, Hemodynamics, Electrophysiology and Intervention
Radiology Laboratories; Design and implementation of Information Management Software
packages unifying the administrative and clinical departments within a single
interface. For more information: www.ngc.it



Web Site: http://www.allium-medical.com

Contact Details: Shlomit Weisblum PR Consultant
Koteret International
Tel. +972 3 575 5778 #4
Mobile +972 54 2152654
Fax +972 3 575 5887
shlomit_w@koteret.com
www.koteret.com